VKTX icon

Viking Therapeutics

140 hedge funds and large institutions have $230M invested in Viking Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 49 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

21% less capital invested

Capital invested by funds: $290M → $230M (-$60M)

31% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 49

Holders
140
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8.28M
Puts
$2.76M
Net Calls
Net Calls Change

Top Buyers

1 +$4.55M
2 +$2.03M
3 +$1.47M
4
SG Americas Securities
SG Americas Securities
New York
+$1.36M
5
Morgan Stanley
Morgan Stanley
New York
+$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.43M
27
$1.39M
28
$1.27M
29
$1.26M
30
$1.23M
31
$1.16M
32
$905K
33
$888K
34
$856K
35
$839K
36
$834K
37
$809K
38
$808K
39
$792K
40
$763K
41
$739K
42
$730K
43
$669K
44
$660K
45
$637K
46
$628K
47
$621K
48
$583K
49
$580K
50
$580K